The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Long-Term Efficacy of a Hepatitis E Vaccine
Open accessAbstract
BACKGROUND: Hepatitis E virus (HEV) is a leading cause of acute hepatitis. The long-term efficacy of a hepatitis E vaccine needs to be determined. METHODS: In an initial efficacy study, we randomly assigned healthy adults 16 to 65 years of age to receive three doses of either a hepatitis E vaccine (vaccine group; 56,302 participants) or a hepatitis B vaccine (control group; 56,302 participants). The vaccines were administered at 0, 1, and 6 months, and the participants were followed for 19 months. In this extended follow-up study, the treatment assignments of all participants remained double-blinded, and follow-up assessments of efficacy, immunogenicity, and safety were continued for up to 4.5 years. RESULTS: During the 4.5-year study period, 60 cases of hepatitis E were identified; 7 cases were confirmed in the vaccine group (0.3 cases per 10,000 person-years), and 53 cases in the control group (2.1 cases per 10,000 person-years), representing a vaccine efficacy of 86.8% (95% confidence interval, 71 to 94) in the modified intention-to-treat analysis, rather than (95% confidence interval, 71 to 84) [corrected]. Of the participants who were assessed for immunogenicity and were seronegative at baseline, 87% of those who received three doses of the hepatitis E vaccine maintained antibodies against HEV for at least 4.5 years; HEV antibody titers developed in 9% in the control group. The rate of adverse events was similar in the two groups. CONCLUSIONS: Immunization with this hepatitis E vaccine induced antibodies against HEV and provided protection against hepatitis E for up to 4.5 years. (Funded by the Chinese Ministry of Science and Technology and others; ClinicalTrials.gov number, NCT01014845.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kamar, N., Bendall, R. P., Abravanel, F., Xia, N., Ijaz, S., Izopet, J., & Dalton, H. R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61849-7 · Cited by 925
Self-citationZhu, F.-C., Zhang, J., Zhang, X.-F., Zhou, C., Wang, Z.-Z., Huang, S.-J., Wang, H., Yang, C.-L., Jiang, H.-M., Cai, J.-P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61030-6 · Cited by 803
Self-citationEmerson, S. U., & Purcell, R. H. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.384 · Cited by 785
The global burden of hepatitis E virus genotypes 1 and 2 in 2005
Rein, D. B., Stevens, G. A., Theaker, J., Wittenborn, J. S., & Wiersma, S. T. (2012) · Hepatology · doi:10.1002/hep.25505 · Cited by 739
Hepatitis E: an emerging infection in developed countries
Dalton, H. R., Bendall, R., Ijaz, S., & Banks, M. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70255-x · Cited by 669
Safety and Efficacy of a Recombinant Hepatitis E Vaccine
Shrestha, M. P., Scott, R. M., Joshi, D. M., Mammen, M. P., Thapa, G. B., Thapa, N., Myint, K. S. A., Fourneau, M., Kuschner, R. A., Shrestha, S. K., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061847 · Cited by 551
Persistent Carriage of Hepatitis E Virus in Patients with HIV Infection
Dalton, H. R., Bendall, R. P., Keane, F. E., Tedder, R. S., & Ijaz, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmc0903778 · Cited by 547
Incidence and severity of viral hepatitis in pregnancy
Khuroo, M. S., Teli, M. R., Skidmore, S., Sofi, M. A., & Khuroo, M. I. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90758-0 · Cited by 546
Hoofnagle, J. H., Nelson, K. E., & Purcell, R. H. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1204512 · Cited by 479
Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy*
Khuroo, M. S., & Kamili, S. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00398.x · Cited by 325
Kumar Acharya, S., Kumar Sharma, P., Singh, R., Kumar Mohanty, S., Madan, K., Kumar Jha, J., & Kumar Panda, S. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.09.016 · Cited by 308
Host Immune Status and Response to Hepatitis E Virus Infection
Krain, L. J., Nelson, K. E., & Labrique, A. B. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00062-13 · Cited by 166
Investigation of hepatitis E outbreak among refugees - Upper Nile, South Sudan, 2012-2013.
Thomson, K. D. B., Luis, D. J., Lagu, J., et al. (2013) · MMWR Morbidity and Mortality Weekly Report · Cited by 102
Exact power and sample size for vaccine efficacy studies
Chan, I., & Bohidar, N. (1998) · Communication in Statistics- Theory and Methods · doi:10.1080/03610929808832160 · Cited by 85
Cited by
EASL Clinical Practice Guidelines on hepatitis E virus infection
Dalton, H. R., Kamar, N., Baylis, S. A., Moradpour, D., Wedemeyer, H., & Negro, F. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.005 · Cited by 665
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission
Sarin, S. K., Kumar, M., Eslam, M., George, J., Al Mahtab, M., Akbar, S. M. F., Jia, J., Tian, Q., Aggarwal, R., Muljono, D. H., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30342-5 · Cited by 525
Self-assembling protein nanoparticles in the design of vaccines
López-Sagaseta, J., Malito, E., Rappuoli, R., & Bottomley, M. J. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2015.11.001 · Cited by 353
Frederiksen, L. S. F., Zhang, Y., Foged, C., & Thakur, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01817 · Cited by 287
Trends in study design and the statistical methods employed in a leading general medicine journal
Gosho, M., Sato, Y., Nagashima, K., & Takahashi, S. (2018) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12605 · Cited by 26
Metadata
- Authors
- Zhang, J., Zhang, X.-F., Huang, S.-J., Wu, T., Hu, Y.-M., Wang, Z.-Z., Wang, H., Jiang, H.-M., Wang, Y.-J., Yan, Q., Guo, M., Liu, X.-H., Li, J.-X., Yang, C.-L., Tang, Q., Jiang, R.-J., Pan, H.-R., Li, Y.-M., Shih, J. W.-K., Ng, M.-H., Zhu, F.-C., & Xia, N.-S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-03-05
- Volume
- 372
- Issue
- 10
- Pages
- 914-922
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139975677
- Cited by
- 378
- References
- 14
- FWCI
- 23.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.